These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 31653527)
1. Monitoring of community-acquired pneumonia hospitalisations before the introduction of pneumococcal conjugate vaccine into Polish National Immunisation Programme (2009-2016): A nationwide retrospective database analysis. Gajewska M; Goryński P; Paradowska-Stankiewicz I; Lewtak K; Piotrowicz M; Urban E; Cianciara D; Wysocki MJ; Książek A; Izurieta P Vaccine; 2020 Jan; 38(2):194-201. PubMed ID: 31653527 [TBL] [Abstract][Full Text] [Related]
2. Effect of the PCV 10 vaccination on community-acquired pneumonia hospitalisations after four years of its introduction into the Polish National Immunisation Programme: Follow-up study. Gajewska M; Lewtak K; Goryński P; Piotrowicz M; Urban E; Paradowska-Stankiewicz I; Rutyna A; Nitsch-Osuch A Vaccine; 2024 May; 42(13):3257-3262. PubMed ID: 38641493 [TBL] [Abstract][Full Text] [Related]
3. Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children. Nair H; Watts AT; Williams LJ; Omer SB; Simpson CR; Willocks LJ; Cameron JC; Campbell H BMC Infect Dis; 2016 Aug; 16():390. PubMed ID: 27506837 [TBL] [Abstract][Full Text] [Related]
4. Epidemiology of hospitalised paediatric community-acquired pneumonia and bacterial pneumonia following the introduction of 13-valent pneumococcal conjugate vaccine in the national immunisation programme in Japan. Takeuchi N; Naito S; Ohkusu M; Abe K; Shizuno K; Takahashi Y; Omata Y; Nakazawa T; Takeshita K; Hishiki H; Hoshino T; Sato Y; Ishiwada N Epidemiol Infect; 2020 Apr; 148():e91. PubMed ID: 32299523 [TBL] [Abstract][Full Text] [Related]
5. Impact of infant pneumococcal conjugate vaccination on community acquired pneumonia hospitalization in all ages in the Netherlands. van Deursen AMM; Schurink-Van't Klooster TM; Man WH; van de Kassteele J; van Gageldonk-Lafeber AB; Bruijning-Verhagen PCJL; de Melker HE; Sanders EAM; Knol MJ Vaccine; 2017 Dec; 35(51):7107-7113. PubMed ID: 29146381 [TBL] [Abstract][Full Text] [Related]
6. Decrease in the incidence and in hospital mortality of community-acquired pneumonia among children in Spain (2001-2014). Jimenez Trujillo I; Lopez de Andres A; Hernandez-Barrera V; Martinez-Huedo MA; de Miguel-Diez J; Jimenez-Garcia R Vaccine; 2017 Jun; 35(30):3733-3740. PubMed ID: 28558982 [TBL] [Abstract][Full Text] [Related]
7. Pneumococcal vaccine effect on hospitalisation rates of pneumonia in children: A meta-analysis. Zhu X; Li X Int J Clin Pract; 2021 Nov; 75(11):e14739. PubMed ID: 34388857 [TBL] [Abstract][Full Text] [Related]
8. Changes in the pneumococcal disease-related hospitalisations in Spain after the replacement of 7-valent by 13-valent conjugate vaccine. Georgalis L; Mozalevskis A; Martínez de Aragón MV; Garrido-Estepa M Eur J Clin Microbiol Infect Dis; 2017 Mar; 36(3):575-583. PubMed ID: 27844262 [TBL] [Abstract][Full Text] [Related]
9. Acute lower respiratory infections in Indigenous infants in Australia's Northern Territory across three eras of pneumococcal conjugate vaccine use (2006-15): a population-based cohort study. Binks MJ; Beissbarth J; Oguoma VM; Pizzutto SJ; Leach AJ; Smith-Vaughan HC; McHugh L; Andrews RM; Webby R; Morris PS; Chang AB Lancet Child Adolesc Health; 2020 Jun; 4(6):425-434. PubMed ID: 32450122 [TBL] [Abstract][Full Text] [Related]
10. Hospitalisation for lower respiratory tract infection in children in the province of Quebec, Canada, before and during the pneumococcal conjugate vaccine era. Anderson G; Deceuninck G; Zhou Z; Boucher FD; Bonnier Viger Y; Gilca R; De Wals P Epidemiol Infect; 2017 Oct; 145(13):2770-2776. PubMed ID: 28803551 [TBL] [Abstract][Full Text] [Related]
11. The burden of hospitalisations for community-acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003-2007). Gil-Prieto R; García-García L; Alvaro-Meca A; Méndez C; García A; de Miguel AG Vaccine; 2011 Jan; 29(3):412-6. PubMed ID: 21111780 [TBL] [Abstract][Full Text] [Related]
12. [Study of hospitalizations for pneumococcal pneumoniae in Centre region, 2004-2008]. Grammatico-Guillon L; Thiercelin N; Mariani S; Lecuyer AI; Goudeau A; Bernard L; Rusch E Rev Epidemiol Sante Publique; 2012 Feb; 60(1):1-8. PubMed ID: 22245493 [TBL] [Abstract][Full Text] [Related]
13. [Clinical burden of multi-cause and pneumococcal pneumonia, meningitis, and septicemia in Hungary. Results of a retrospective study (2006-2011)]. Ludwig E; Jorgensen L; Gray S; Munson S; Chou K; Gutterman EM Orv Hetil; 2014 Sep; 155(36):1426-36. PubMed ID: 25176517 [TBL] [Abstract][Full Text] [Related]
14. Pneumonia hospitalisation and case-fatality rates in older Australians with and without risk factors for pneumococcal disease: implications for vaccine policy. Dirmesropian S; Liu B; Wood JG; MacIntyre CR; McIntyre P; Karki S; Jayasinghe S; Newall AT Epidemiol Infect; 2019 Jan; 147():e118. PubMed ID: 30869015 [TBL] [Abstract][Full Text] [Related]
15. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Grijalva CG; Nuorti JP; Arbogast PG; Martin SW; Edwards KM; Griffin MR Lancet; 2007 Apr; 369(9568):1179-86. PubMed ID: 17416262 [TBL] [Abstract][Full Text] [Related]
16. Changes in hospitalizations for pneumonia after universal vaccination with pneumococcal conjugate vaccines 7/13 valent and haemophilus influenzae type b conjugate vaccine in a Pediatric Referral Hospital in Uruguay. Pírez MC; Algorta G; Chamorro F; Romero C; Varela A; Cedres A; Giachetto G; Montano A Pediatr Infect Dis J; 2014 Jul; 33(7):753-9. PubMed ID: 24492286 [TBL] [Abstract][Full Text] [Related]
17. Pneumonia hospitalizations of children aged <2 years in Poland before (2013-2016) and after (2017-2018) universal mass vaccination with 10-valent pneumococcal non-typeable Bhavsar A; Zaryczański J; Wasilewska A; Saragoussi D; Devadiga R; Colby C; Bahar E; Wysocki J Hum Vaccin Immunother; 2022 Nov; 18(6):2128566. PubMed ID: 36239615 [TBL] [Abstract][Full Text] [Related]
18. Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature. Tsaban G; Ben-Shimol S Vaccine; 2017 May; 35(22):2882-2891. PubMed ID: 28449971 [TBL] [Abstract][Full Text] [Related]
19. The impact of pneumococcal conjugate vaccine on community-acquired pneumonia hospitalizations in children with comorbidity. Sterky E; Bennet R; Lindstrand A; Eriksson M; Nilsson A Eur J Pediatr; 2017 Mar; 176(3):337-342. PubMed ID: 28070670 [TBL] [Abstract][Full Text] [Related]
20. Paediatric community-acquired bacteraemia, pneumococcal invasive disease and antibiotic resistance fell after the pneumococcal conjugate vaccine was introduced. Berger Y; Adler A; Ariel T; Rokney A; Averbuch D; Grisaru-Soen G Acta Paediatr; 2019 Jul; 108(7):1321-1328. PubMed ID: 30506762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]